作者：
Brian S,Wojeck [1]
;
Silvio E,Inzucchi [2]
;
Ian J,Neeland [3]
;
James P,Mancuso [4]
;
Robert,Frederich [5]
;
Urszula,Masiukiewicz [2]
;
Nilo B,Cater [4]
;
Darren K,McGuire [6]
;
Christopher P,Cannon [7]
;
Henry Klar,Yaggi [8]
作者单位：
Section of Endocrinology, Yale School of Medicine, 33 Cedar Street, P.O. Box 208020, New Haven, CT, 06520, USA. Brian.Wojeck@yale.edu.
[1]
Section of Endocrinology, Yale School of Medicine, 33 Cedar Street, P.O. Box 208020, New Haven, CT, 06520, USA.
[2]
Harrington Heart and Vascular Institute University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Cleveland, OH, USA.
[3]
Pfizer Inc, Groton, CT, USA.
[4]
Pfizer Inc, Collegeville, PA, USA.
[5]
Pfizer Inc, New York, NY, USA.
[6]
University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas, TX, USA.
[7]
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
[8]
Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
[9]
The VA CT Clinical Epidemiology Research Center, West Haven, CT, USA.
[10]
DOI
10.1007/s11325-022-02594-2
PMID
35596030
发布时间
2024-03-10
换一批
换一批
